Workshop on Handling of OOS Test Results (FDA&MHRA)
- Written by Chief Editor Tue, 14 Jun 22 PM
Inadequate investigation of out of specification(OOS) results in the laboratory is common observation cited in FDA483s and warning letters.
This workshop
organized by pharma coach Bhaskar Napte with the aim to develop an
understanding of how a compliant laboratory handles the investigation of OOS
test observations and how the laboratory interfaces with other units through
the laboratory investigation practices.
The interactive
live discussion will be based on the FDA&MHRA guidance on handling OOS
laboratory results and to provide a clear process for compliant laboratory OOS
Investigations
Topics of the Workshop include
ü
Latest
regulatory expectations on OOS
ü
The
OOS investigation process
ü
Phase
I,II&III investigation
ü
Additional
laboratory testing
ü
Batch
disposition decision
ü
FAR
&Quality Defect report
ü
Outliers
tests(statistical evaluation)
ü
Key
elements to avoid OOS
The workshop will take place on Wednesday, 15th June 2022, from 08:00 pm to 10:30pm (IST)
For more the registration to the workshop please click here